phospholipase A2 inhibitors (McGill)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namephospholipase A2 inhibitors (McGill)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhospholipases A2 inhibitors
TargetsPhospholipases A2
Therapy Area/IndicationsSpinal Cord InjuriesMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMcGill University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMcGill University
Active IndicationsN/A
Inactive IndicationsSpinal Cord InjuriesMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A